MedTrace Logo

Clinical Evaluation of Approved and Investigational Contact Lenses Using New UV Additive

NCT02982018 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 133

Last updated 2018-07-19

Study results available
· View outcomes & findings →

Summary

Randomized, 8-visit dispensing study over 14 weeks to evaluate the safety and efficacy of an investigational contact lens with a new UV blocker compared to a marketed contact lens.

Conditions

  • Visual Acuity

Interventions

DEVICE

senofilcon A with new UV blocker

Investigational Contact Lens

DEVICE

senofilcon A

J\&J Marketed Contact Lens

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-01
Primary Completion
2017-02-18
Completion
2017-02-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02982018 on ClinicalTrials.gov